WallStSmart
DXR

Daxor Corporation

NASDAQ: DXR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$10.80
+1.41% today

Updated 2026-04-30

Market cap
$59.73M
P/E ratio
6.25
P/S ratio
2,238.07x
EPS (TTM)
$1.64
Dividend yield
52W range
$7 – $15
Volume
0.0M

Daxor Corporation (DXR) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-3.44M$-3.14M$-4.04M$-5.25M$-5.69M$-6.51M$4.48M$-9.04M$-295636.00$18.53M$1.59M$-1.17M$-1.32M$3.11M$-2.45M$-2.76M$-769298.00$-3.66M$25692.00$-604420.00
Capital expenditures$344534.00$1.64M$666310.00$2.17M$324710.00$123150.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$3.00$4.00$1.00$4.00$0.00
Depreciation
Stock-based comp$5838.00$2232.00$7535.00$10325.00$13508.00$83834.00$199358.00$377607.00$729336.00$786642.00$631701.00
Free cash flow$-3.78M$-4.79M$-4.71M$-7.42M$-6.01M$-6.63M$4.48M$-9.04M$-295636.00$18.53M$1.59M$-1.17M$-1.32M$3.11M$-2.45M$-2.76M$-769302.00$-3.66M$25688.00$-604420.00
Investing cash flow
Financing cash flow
Dividends paid$6.45M$5.74M$4.23M$1.05M$833386.00$204549.00$119751.00$154102.00$113989.00$112102.00
Share repurchases
Debt repayment
Net change in cash$1884.00